Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry.

Res Pract Thromb Haemost · 2025 · PMC12664498 · PMID 41322968

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The correlation was highly significant for thromboelastometry clotting time, but only when the procedure was performed without exogenous triggers.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.